1.近期在2026年1月7号,外媒透露艾伯维正就收购 Revolution Medicines 展开深入谈判,这笔交易价值可能超 200 亿美元。当天 Revolution Medicines 的市值约为 160 亿美元,这意味着收购报价较其市值存在 25% 的显著溢价。若交易达成,将成为近年来规模较大的医疗保健领域并购案之一。该消息迅速刺激市场,Revolution Medicines 的股价...
Source Link1.近期在2026年1月7号,外媒透露艾伯维正就收购 Revolution Medicines 展开深入谈判,这笔交易价值可能超 200 亿美元。当天 Revolution Medicines 的市值约为 160 亿美元,这意味着收购报价较其市值存在 25% 的显著溢价。若交易达成,将成为近年来规模较大的医疗保健领域并购案之一。该消息迅速刺激市场,Revolution Medicines 的股价...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.